Skip to content
April 22, 2026
Balchem Releases 2025 Sustainability Report
April 16, 2026
Thailand FDA Approval of OptiMSM® Expands Innovation Opportunities
April 16, 2026
Balchem Announces Conference Call for First Quarter 2026 Financial Results
April 2, 2026
New Clinical Study Uncovers Potential K2VITAL™ Post-Exercise Neuromuscular Signaling in Older Adults
March 9, 2026
Balchem Plant Nutrition Launches Metalosate® T.E.A.M.™ Plant Tissue Analysis Digital Platform
February 25, 2026
Balchem to Participate in the BNP Paribas Exane Consumer Ingredients & Chemicals Conference on March 11, 2026
February 24, 2026
Balchem to Participate in the JP Morgan Consumer Ingredients Forum on March 10, 2026
February 20, 2026
Balchem Reports Fourth Quarter and Full Year 2025 Financial Results
February 6, 2026
Balchem Announces Conference Call for Fourth Quarter and Full Year 2025 Financial Results
January 2, 2026
Balchem to Attend the CJS Securities 26th Annual New Ideas for the New Year Virtual Conference on January 14, 2026